High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-10-05
DOI
https://doi.org/10.1186/s12885-026-17060-5
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival

Kaile Zhang, Ming Jiang, Jia Hou, Mengyuan Chen et al.
BMC Cancer
Multiple Myeloma Research and Treatments
article

High-dose melphalan and autologous stem cell transplantation in multiple myeloma: efficacy and minimal residual disease’s impact on progression-free survival

Kaile Zhang, Ming Jiang, Jia Hou, Mengyuan Chen, Ruixue Yang, Jianli Xu, Chunxia Han, Hailong Yuan, Gang Chen
article en

Abstract

No abstract available for this paper.
BMC Cancer
Xinjiang Medical University (CN), First Affiliated Hospital of Xinjiang Medical University (CN)
Openalex Percentile: Top 12%
Multiple Myeloma Research and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.